BACKGROUND: The Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L) is a novel cognitive test that measures recovery from proactive semantic interference, which may be an early cognitive marker of Alzheimer's disease (AD). OBJECTIVE: To generate normative data for a Spaniard population and to validate the LASSI-L for the diagnosis of amnestic mild cognitive impairment (aMCI) and mild AD. METHODS: We performed a cross-sectional study in which 97 healthy participants, 34 with aMCI, and 33 with mild AD were studied with LASSI-L and a comprehensive neuropsychological protocol. The overlapping strategy analysis was used to maximize the sample size and to provide age- and education-adjusted normative data using a logistic regression analysis. RESULTS: Internal consistency was 0.932. Convergent validity with the Free and Cued Selective Reminding Test was moderate. LASSI-L raw scores were correlated with age and years of education, but not gender. The area under the curve for discriminating between healthy controls and aMCI was 0.909, and between healthy controls and mild AD was 0.986. LASSI-L sub-scores representing maximum storage capacity, recovery from proactive interference, and delayed recall yielded the highest diagnostic accuracy. CONCLUSIONS: The LASSI-L is a reliable and valid test for the diagnosis of aMCI and mild AD. The age and education influences on the performance of the test and normative data are provided. LASSI-L merits further studies to evaluate its ability to detect preclinical AD and predict progression to aMCI and early dementia.
BACKGROUND: The Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L) is a novel cognitive test that measures recovery from proactive semantic interference, which may be an early cognitive marker of Alzheimer's disease (AD). OBJECTIVE: To generate normative data for a Spaniard population and to validate the LASSI-L for the diagnosis of amnestic mild cognitive impairment (aMCI) and mild AD. METHODS: We performed a cross-sectional study in which 97 healthy participants, 34 with aMCI, and 33 with mild AD were studied with LASSI-L and a comprehensive neuropsychological protocol. The overlapping strategy analysis was used to maximize the sample size and to provide age- and education-adjusted normative data using a logistic regression analysis. RESULTS: Internal consistency was 0.932. Convergent validity with the Free and Cued Selective Reminding Test was moderate. LASSI-L raw scores were correlated with age and years of education, but not gender. The area under the curve for discriminating between healthy controls and aMCI was 0.909, and between healthy controls and mild AD was 0.986. LASSI-L sub-scores representing maximum storage capacity, recovery from proactive interference, and delayed recall yielded the highest diagnostic accuracy. CONCLUSIONS: The LASSI-L is a reliable and valid test for the diagnosis of aMCI and mild AD. The age and education influences on the performance of the test and normative data are provided. LASSI-L merits further studies to evaluate its ability to detect preclinical AD and predict progression to aMCI and early dementia.
Authors: Jordi Peña-Casanova; Nina Gramunt-Fombuena; Sonia Quiñones-Ubeda; Gonzalo Sánchez-Benavides; Miquel Aguilar; Dolors Badenes; José Luis Molinuevo; Alfredo Robles; Maria Sagrario Barquero; María Payno; Carmen Antúnez; Carlos Martínez-Parra; Anna Frank-García; Manuel Fernández; Verónica Alfonso; Josep M Sol; Rafael Blesa Journal: Arch Clin Neuropsychol Date: 2009-08-06 Impact factor: 2.813
Authors: Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling Journal: Neuropsychologia Date: 2011-06-12 Impact factor: 3.139
Authors: Kathryn V Papp; Rebecca E Amariglio; Elizabeth C Mormino; Trey Hedden; Maria Dekhytar; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Neuropsychologia Date: 2015-05-19 Impact factor: 3.139
Authors: Miranka Wirth; Cindee M Madison; Gil D Rabinovici; Hwamee Oh; Susan M Landau; William J Jagust Journal: J Neurosci Date: 2013-03-27 Impact factor: 6.167
Authors: Elizabeth Crocco; Rosie E Curiel; Amarilis Acevedo; Sara J Czaja; David A Loewenstein Journal: Am J Geriatr Psychiatry Date: 2013-06-12 Impact factor: 4.105
Authors: Dorene M Rentz; Mario A Parra Rodriguez; Rebecca Amariglio; Yaakov Stern; Reisa Sperling; Steven Ferris Journal: Alzheimers Res Ther Date: 2013-11-21 Impact factor: 6.982
Authors: Elizabeth A Crocco; David A Loewenstein; Rosie E Curiel; Noam Alperin; Sara J Czaja; Philip D Harvey; Xiaoyan Sun; Joshua Lenchus; Arlene Raffo; Ailyn Peñate; Jose Melo; Lee Sang; Rosemery Valdivia; Karen Cardenas Journal: J Psychiatr Res Date: 2017-08-24 Impact factor: 4.791
Authors: Marcela Kitaigorodsky; Rosie E Curiel Cid; Elizabeth Crocco; Katherine L Gorman; Christian J González-Jiménez; Maria Greig-Custo; Warren W Barker; Ranjan Duara; David A Loewenstein Journal: J Psychiatr Res Date: 2021-08-26 Impact factor: 4.791
Authors: David A Loewenstein; Rosie E Curiel; Steven DeKosky; Russell M Bauer; Monica Rosselli; Salvador M Guinjoan; Malek Adjouadi; Ailyn Peñate; William W Barker; Sindy Goenaga; Todd Golde; Maria T Greig-Custo; Kevin S Hanson; Chunfei Li; Gabriel Lizarraga; Michael Marsiske; Ranjan Duara Journal: Neurology Date: 2018-08-03 Impact factor: 9.910
Authors: Marcela Kitaigorodsky; Elizabeth Crocco; Rosie E Curiel-Cid; Giselle Leal; Diane Zheng; Melissa K Eustache; Maria T Greig-Custo; William Barker; Ranjan Duara; David A Loewenstein Journal: Alzheimers Dement (Amst) Date: 2021-05-25
Authors: Rosie E Curiel; David A Loewenstein; Monica Rosselli; Ailyn Penate; Maria T Greig-Custo; Russell M Bauer; Salvador M Guinjoan; Kevin S Hanson; Chunfei Li; Gabriel Lizarraga; William W Barker; Valeria Torres; Steven DeKosky; Malek Adjouadi; Ranjan Duara Journal: Curr Alzheimer Res Date: 2018 Impact factor: 3.040